Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Rittman

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Biological Psychiatry|March 25, 2014
Improving response inhibition in Parkinson's disease with atomoxetineZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 30, 2020
In vivo PET imaging of neuroinflammation in familial frontotemporal dementiaMaura Malpetti, Timothy Rittman, Peter Simon Jones, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 1, 2019
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical featuresAudrey Low, Elijah Mak, Maura Malpetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2021
Neuroinflammation predicts disease progression in progressive supranuclear palsyMaura Malpetti, Luca Passamonti, Peter Simon Jones, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 11, 2016
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's DiseaseRobin J Borchert, Timothy Rittman, Luca Passamonti, et al.
Annals of Clinical and Translational Neurology|June 16, 2021
Synaptic density in carriers of C9orf72 mutations: a [<sup>11</sup> C]UCB-J PET studyMaura Malpetti, Negin Holland, P Simon Jones, et al.
Brain : a Journal of Neurology|September 23, 2025
The presymptomatic and early manifestations of semantic dementiaDavid J Whiteside, Matthew A Rouse, P Simon Jones, et al.
Science Advances|October 29, 2021
In vivo rate-determining steps of tau seed accumulation in Alzheimer's diseaseGeorg Meisl, Eric Hidari, Kieren Allinson, et al.
Brain : a Journal of Neurology|June 26, 2016
Atomoxetine restores the response inhibition network in Parkinson's diseaseCharlotte L Rae, Cristina Nombela, Patricia Vázquez Rodríguez, et al.
Brain : a Journal of Neurology|August 16, 2021
Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET studyNegin Holland, Maura Malpetti, Timothy Rittman, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Biological Psychiatry|March 25, 2014
Improving response inhibition in Parkinson's disease with atomoxetineZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 30, 2020
In vivo PET imaging of neuroinflammation in familial frontotemporal dementiaMaura Malpetti, Timothy Rittman, Peter Simon Jones, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 1, 2019
Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical featuresAudrey Low, Elijah Mak, Maura Malpetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2021
Neuroinflammation predicts disease progression in progressive supranuclear palsyMaura Malpetti, Luca Passamonti, Peter Simon Jones, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 11, 2016
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's DiseaseRobin J Borchert, Timothy Rittman, Luca Passamonti, et al.
Annals of Clinical and Translational Neurology|June 16, 2021
Synaptic density in carriers of C9orf72 mutations: a [<sup>11</sup> C]UCB-J PET studyMaura Malpetti, Negin Holland, P Simon Jones, et al.
Brain : a Journal of Neurology|September 23, 2025
The presymptomatic and early manifestations of semantic dementiaDavid J Whiteside, Matthew A Rouse, P Simon Jones, et al.
Science Advances|October 29, 2021
In vivo rate-determining steps of tau seed accumulation in Alzheimer's diseaseGeorg Meisl, Eric Hidari, Kieren Allinson, et al.
Brain : a Journal of Neurology|June 26, 2016
Atomoxetine restores the response inhibition network in Parkinson's diseaseCharlotte L Rae, Cristina Nombela, Patricia Vázquez Rodríguez, et al.
Brain : a Journal of Neurology|August 16, 2021
Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET studyNegin Holland, Maura Malpetti, Timothy Rittman, et al.
Pageof 9